MEA Body Composition Analyzers Market

MEA Body Composition Analyzers Market Size (2023 to 2028)

As per the research report, the Body Composition Analyzers Market in the Middle East and Africa was worth USD 69.15 million in 2023. It is projected to be growing at a CAGR of 9.96%, to touch USD 111.17 million by 2028.

The main purpose of a Body Composition Analyzers is to measure the fractions of fat, bone, water, and muscle present in the human body. BCAs are useful in determining muscularity, particularly in the fitness & sports industry, while also catering to the people's growing health awareness.

Healthy body composition refers to the one that includes a lower proportion of body fat and a higher proportion of fat-free or lean mass. Since muscular tissue takes up lesser space in the body compared to fat tissue, leanness is determined by the body weight and body composition. Body composition analyzers determine body composition and aid in determining the risk of individuals developing diseases like truncal and abdominal obesity.

The growth of the Middle East and Africa Body Composition Analyzers Market is driven by the increasing consciousness of people towards health and fitness, expanding obese populace, increasing utility of these analyzers in the sports and fitness industry, and the rising government incentives to encourage fitness consciousness and physical activity among people, are expected to be the drivers of market growth.

However, the high cost of the equipment and the inaccuracy of various analyzers are some of the constraints faced by the market.

This research report on the MEA Body Composition Analyzers Market has been segmented and sub-segmented into the following categories:

By Product: 

• Bio-impedance Analyser
• DEXA
• Skinfold Callipers
• ADP
• Hydrostatic Weighing

By End-users: 

• Hospitals
• Fitness & Wellness Centres
• Academic & Research Centres
• Home-users

By Country: 

• KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA

Geographically, the increasing number of private and public diagnostic centers involving modern imaging techniques, which consequently lead to increased demand for contrast media, are expected to drive the region's market growth in the near future. The presence of huge untapped markets, particularly in the countries of Africa, further offers the potential for market growth.

Companies playing a leading role in the MEA Body Composition Analyzers Market profiled in the report are InBody Co., Ltd (South Korea), Tanita Corporation (Japan), Omron Corporation (Japan), Hologic, Inc. (U.S.), and GE Healthcare (U.S.) among others.